Archives
Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Mechanism, Eviden...
Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Mechanism, Evidence & Translational Utility
Executive Summary: The Cy3 Goat Anti-Mouse IgG (H+L) Antibody (K1207) is an affinity-purified, Cy3-conjugated polyclonal secondary antibody that enables sensitive, specific detection of mouse immunoglobulins in fluorescence-based assays (APExBIO). The Cy3 fluorophore provides strong emission at 570 nm for high-contrast imaging. The antibody is validated for key research applications including immunofluorescence, immunohistochemistry, and flow cytometry. Signal amplification is achieved by multiple secondary antibodies binding to each primary, increasing assay sensitivity. Proper storage and handling are critical to maintain fluorescence and specificity (Xiong et al., 2024).
Biological Rationale
Fluorescence-based immunoassays are essential for detecting specific proteins in complex biological samples. Mouse monoclonal antibodies are widely used as primaries due to their specificity. However, their signals often require amplification and visualization. The Cy3 Goat Anti-Mouse IgG (H+L) Antibody addresses this by binding to mouse IgG heavy and light chains, enabling detection via Cy3 fluorescence. Cy3 emits at 570 nm, providing a bright, photostable signal suitable for multiplexing with other fluorophores (see mechanism discussion). In translational oncology, such as studies dissecting the tumor microenvironment and resistance mechanisms in prostate cancer, reliable secondary detection is critical for quantifying cellular markers (Xiong et al., 2024).
Mechanism of Action of Cy3 Goat Anti-Mouse IgG (H+L) Antibody
This antibody is generated by immunizing goats with pooled mouse IgG, followed by immunoaffinity chromatography for purification. The resulting polyclonal antibody is conjugated to Cy3, a sulfoindocyanine dye providing strong fluorescence and low background. The antibody recognizes both heavy and light chains of mouse IgG, allowing detection of all subclasses (IgG1, IgG2a, IgG2b, IgG3) in research samples. Upon incubation with mouse primary antibody-bound targets, the Cy3-conjugated secondary binds via Fc or Fab region interactions. Each primary antibody can be bound by multiple secondary antibodies, amplifying the fluorescent signal. Cy3 excitation (550 nm) and emission (570 nm) spectra are compatible with standard filter sets (product data).
Evidence & Benchmarks
- Affinity-purified Cy3 Goat Anti-Mouse IgG (H+L) Antibody enables detection limits down to picogram (pg) levels of mouse IgG in immunofluorescence (see validation data).
- Demonstrated high specificity with minimal cross-reactivity to non-mouse species when tested by ELISA and immunoblotting (APExBIO datasheet).
- Maintains >90% fluorescence intensity after 12 months storage at -20°C in 23% glycerol, PBS, 1% BSA, 0.02% sodium azide; avoid freeze/thaw cycles (storage study).
- Enables robust signal amplification in multiplex assays by binding multiple secondary antibodies per primary, improving sensitivity in flow cytometry and immunofluorescence (Xiong et al., 2024).
- Validated for use in immunohistochemistry (IHC), immunofluorescence (IF), and flow cytometry (FC) in translational research settings (application summary).
Applications, Limits & Misconceptions
The Cy3 Goat Anti-Mouse IgG (H+L) Antibody is suitable for diverse applications:
- Immunofluorescence (IF): Enables visualization of cellular proteins with high sensitivity and spatial resolution.
- Flow Cytometry (FC): Quantifies surface and intracellular antigens in single cell suspensions.
- Immunohistochemistry (IHC): Detects mouse IgG-bound antigens in tissue sections.
- Multiplexing: Cy3 spectral properties allow combination with FITC, DAPI, and Cy5 for multi-marker analysis.
In comparative context, Redefining Biomarker Discovery reviewed early disease biomarker detection using this antibody; the present article extends this by detailing mechanism and storage parameters for reproducibility. Recent work such as Illuminating Resistance focused on translational applications in the tumor microenvironment; here, we clarify the molecular underpinnings and performance benchmarks. For next-generation quantitative proteomics, see Unraveling Quantitative Discovery; this article updates stability and specificity evidence.
Common Pitfalls or Misconceptions
- Not species-specific for non-mouse primaries: The antibody is not intended for detecting rabbit or human IgG; cross-reactivity may occur if used improperly (datasheet).
- Photobleaching risk: Cy3 is sensitive to prolonged light exposure; always protect samples from light to maintain signal integrity.
- Freeze/thaw cycles degrade fluorescence: Repeated freezing and thawing can reduce Cy3 signal and antibody binding affinity.
- Not for therapeutic use: For research use only; not suitable for diagnostic or clinical applications.
- Buffer incompatibilities: High concentrations of reducing agents or detergents can affect Cy3 fluorescence and antibody stability.
Workflow Integration & Parameters
- Storage: Store at 4°C for short term (≤2 weeks); for long-term, aliquot and freeze at -20°C. Avoid light and freeze/thaw cycles.
- Working dilution: Typical working concentrations range from 1–10 μg/mL, depending on assay type and signal requirements.
- Buffer compatibility: Supplied in PBS, 23% glycerol, 1% BSA, 0.02% sodium azide for stability.
- Sample compatibility: Validated for use in cell cultures, tissue sections, and single-cell suspensions.
- Controls: Always include negative and isotype controls to confirm specificity.
Refer to the K1207 product page for detailed protocols, lot-specific performance data, and troubleshooting tips.
Conclusion & Outlook
The Cy3 Goat Anti-Mouse IgG (H+L) Antibody from APExBIO is a validated, high-performance secondary antibody for sensitive and specific detection of mouse IgG in fluorescence-based assays. Its robust signal amplification, photostable Cy3 fluorophore, and broad assay compatibility make it a key reagent for translational research, biomarker discovery, and mechanistic studies of disease resistance. As multiplex immunoassays and quantitative proteomics advance, the mechanistic and technical clarity provided here enables researchers to deploy this reagent with confidence and reproducibility. For further applications and mechanistic analysis, consult recent peer-reviewed evidence (Xiong et al., 2024).